Latest News
LabGenius uses Graphcore’s IPUs to speed up drug discovery

LabGenius uses Graphcore’s IPUs to speed up drug discovery

AI-driven scientific research firm LabGenius is harnessing the power of Graphcore’s IPUs (Intelligence Processing Units) to speed up its drug discovery efforts.

LabGenius is currently focused on discovering new treatments for cancer and inflammatory diseases. The firm combines AI, lab automation, and synthetic biology for its potentially life-saving work.

Until now, the company has been using traditional GPUs for its workloads. LabGenius reports that switching to Graphcore’s IPUs in cloud instances from Cirrascale Cloud Services enabled its training of models to be reduced from one month to around two weeks.

“Previously we used GPUs and it took us about a month to have a functioning model of all the proteins that are out there,” said Dr Katya Putintseva, a Machine Learning Advisor to LabGenius.

“With Graphcore, we reduced the turnaround time to about two weeks, so we can experiment much more rapidly and we can see the results quicker.”

Specifically, LabGenius is using IPUs from Bristol, UK-based Graphcore to train a BERT Transformer model on a large data set of known proteins to predict masked amino acids. This, the company says, enables the model to effectively learn the basic biophysics of proteins.

“[The system] is looking across different features we could change about the molecule — from point mutations of simpler constructs to the overall composition and topology of multi-module proteins,” explained Tom Ashworth, Head of Technology at LabGenius.

“It’s making suggestions about what to design next… to learn about a change in the input and how that maps to a change in the output.”

One in two people now develop cancer in their lifetime. Current treatments often cause much suffering themselves and, while survival rates for most forms are increasing, only around 50 percent survive for ten years or more.

AI will help to find new cancer treatments that cause less suffering and greatly increase the odds of long-term survivability. However, while discovering new cancer treatments is the current focus of LabGenius, the company notes how the principles can be applied more widely to find new treatments for other horrible diseases that plague mankind.

“Graphcore has changed what we’re able to do, accelerating our model training time from weeks to days,” adds Ashworth.

“For our data scientists, that’s really transformative. They can move much more at the speed they think.”

(Photo by National Cancer Institute on Unsplash)

Want to learn more about AI and big data from industry leaders? Check out AI & Big Data Expo taking place in Amsterdam, California, and London.

Explore other upcoming enterprise technology events and webinars powered by TechForge here.

Tags: ai, artificial intelligenc, artificial intelligence, bert, cancer, drug discovery, drugs, graphcore, health, healthcare, intelligence processing unit, ipu, labgenius, medicine, Model, treatment

Source link

Leave a Reply

Your email address will not be published.